Dyadic to appear at New York conference

26 Aug '05

1 min read

Biological products developer Dyadic International Inc announced that its President and CEO, Mark Emalfarb, will present at the Roth Capital Partners New York Conference to be held on September 7-8, 2005, at the Westin New York at Times Square.

Dyadic's investor presentation is scheduled for Thursday, September 8th at 9:00 a.m. EDT. The presentation will be webcast live and archived online for 30 days on the Investor Relations section of the company's website.

Leading biological firm Dyadic International Inc, is engaged in the development, produces and sale of biological products (proteins, enzymes, peptides and other bio-molecules), as well as the licensing of its enabling proprietary technology to business collaborators for the discovery, development and manufacture of biological products from genes. Dyadic markets its products and services for applications in the textile, chemical, agricultural, pulp & paper, pharmaceutical, biotechnology and other industries, using its proprietary C1 Host Technology and C1 Expression and Screening Systems for the discovery, development and production of biological products.

Florida based Dyadic, founded in 1979, has significant experience in the discovery, development, manufacturing and commercialization of specialty enzymes and chemicals for the textile, animal feed, and paper and pulp industries.

Dyadic International Inc

More Dyadic International Inc News... More Textiles News - United States Of America...